Profile: Specialty Laboratories is a full-service, clinical reference laboratory, which concentrates on partnering with hospitals to support their role in community-based medicine and to reduce costs for episodes of care. Our AmpliChip™ is the first FDA-cleared microarray assay to identify an individual's genetic variation in two critical drug metabolism genes, CYP2D6 and CYP2C19. Our Ganglioside Asialo-GM1 Autoabs test is used to aid in the diagnosis of motor/sensory neuropathy. Asialo-GM1 autoantibodies, in the absence of correspondingly high concentrations of GM1 autoantibodies, identify a subset of patients with motor neuron disease exhibiting proximal muscle weakness in the early stages.

The company was founded in 1975, has ~280 employees.